SCIENTIFIC BACKGROUND

SH2D1A

Category:

Scientific Background

X-linked lymphoproliferative syndrome (XLP1) is a primary immunodeficiency that causes an uncontrolled immune response to a primary EBV infection. Infection leads to proliferation of B‑lymphocytes and cytotoxic T-lymphocytes with fulminant infectious mononucleosis, B-cell lymphomas, immune deficiency or, more rarely, aplastic anemia, necrotizing vasculitis and lymphoid granulomatosis. Before EBV infection, which occurs at the age of 5 years on average, most patients are clinically healthy and other viral infections result in normal immune responses. In fulminant infectious mononucleosis, over 60% of patients die of acute liver failure. EBV-associated hemophagocytic syndrome with bone marrow aplasia also has a high mortality rate. As the disease progresses, a combined immunodeficiency with hypogammaglobulinemia, similar to common variable immune deficiency (CVID), often occurs. About 30% of patients develop malignancies, especially non-Hodgkin lymphomas of the Burkitt type. XLP1 has the highest risk of malignancy of all immune defects. Peripheral blood shows lymphocytosis with atypical lymphocytes and abnormal lymphocyte functions, the CD4:CD8 ratio is shifted in favor of the CD8 cells. EBV titers may be low or undetectable. The therapy of choice today is bone marrow or stem cell transplantation, without which about 70% of patients die before the age of 10.

 

The disease is caused by mutations in the SH2D1A gene (SH2 domain-containing gene 1A), whose gene product, as an adaptor protein, plays a role in signal transduction mediated by SLAM (CD150) and 2B4 (NK cell activating receptor, CD244), among other things. Reduced protein expression leads to severely limited T and NK cell-mediated cytotoxicity and to the absence of inhibitory NkT cells and B memory cells. Carriers are normally clinically healthy.

 

References

https://www.ncbi.nlm.nih.gov/pubmed/29670631# Panchal et al. 2018, Front Immunol 9:666 / Zhang et al. 2016, GeneReviews® [Internet], https://www.ncbi.nlm.nih.gov/books/NBK1406/ / Booth et al. 2011, Blood 117:53 / Rezaei et al. 2011, Br J Haemat 152:13 / Nichols et al. 2005, Nature Med 1:340

GENES

SH2D1A

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa...

Read more

Aneuploidies, such as translocations, whole or segmental chromosomal duplications, and deletions, are examples of chromosomal abnormalities that are ...

Read more

Here you can read the winning essays from the first, annual DNA essay competition on the subject of "How unfolding the DNA code can help with precisi...

Read more

Introduction Our voices are as unique as our fingerprints! Although there are people whose voices might sound alike, there are no two voices exact...

Read more

Not everyone likes winter. For people who do not enjoy the cold weather, or having to put on a thick coat to go outside, a winter can be a source of ...

Read more